• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘患者吸入沙美特罗的药代动力学分析:来自两种干粉吸入器的证据。

Pharmacokinetic analysis of inhaled salmeterol in asthma patients: Evidence from two dry powder inhalers.

作者信息

Soulele Konstantina, Macheras Panos, Karalis Vangelis

机构信息

Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, University Campus, Athens, 157 84, Greece.

出版信息

Biopharm Drug Dispos. 2017 Oct;38(7):407-419. doi: 10.1002/bdd.2077. Epub 2017 Jul 12.

DOI:10.1002/bdd.2077
PMID:28374512
Abstract

Salmeterol (SAL) is a long-acting β2-adrenergic agonist, which is widely used in the therapy of asthma. The aim of this study was to investigate the pharmacokinetics (PK) of inhaled salmeterol in asthma patients using two different dry powder inhalers. This analysis was based on data from 45 subjects who participated in a two-sequence, four-period crossover bioequivalence (BE) study after single administration of the test (T) and reference (R) products. In order to mimic more closely the real treatment conditions, activated charcoal was not co-administered. Plasma concentration-time (C-t) data were initially analysed using classic non-compartmental PK approaches, while the main objective of the study was to apply population PK modeling. The relative fraction of the dose absorbed via the lungs (R ) was set as a parameter in the structural model. The plasma C-t profiles of salmeterol showed a biphasic time course indicating a parallel pulmonary and gastrointestinal (GI) absorption. A two-compartment disposition model with first order absorption from the GI and very rapid absorption from lungs (like an i.v. bolus) was found to describe successfully the C-t profiles of salmeterol. The estimated R value was 13% suggesting a high gut deposition of inhaled salmeterol. Women were found to exert less capability to eliminate salmeterol than men, while body weight (in allometric form) was found to be an important covariate on the peripheral volume of distribution.

摘要

沙美特罗(SAL)是一种长效β2肾上腺素能激动剂,广泛用于哮喘治疗。本研究的目的是使用两种不同的干粉吸入器,研究哮喘患者吸入沙美特罗的药代动力学(PK)。该分析基于45名受试者的数据,这些受试者在单次服用试验(T)和参比(R)产品后,参与了一项两序列、四周期交叉生物等效性(BE)研究。为了更接近真实治疗情况,未同时给予活性炭。血浆浓度-时间(C-t)数据最初使用经典的非房室PK方法进行分析,而该研究的主要目的是应用群体PK建模。通过肺部吸收的剂量相对分数(R)被设定为结构模型中的一个参数。沙美特罗的血浆C-t曲线显示出双相时间过程,表明肺部和胃肠道(GI)吸收平行。发现一个二房室处置模型成功地描述了沙美特罗的C-t曲线,该模型具有从胃肠道的一级吸收和从肺部的非常快速的吸收(类似于静脉推注)。估计的R值为13%,表明吸入的沙美特罗在肠道沉积较多。发现女性消除沙美特罗的能力低于男性,而体重(以异速生长形式)是外周分布容积的一个重要协变量。

相似文献

1
Pharmacokinetic analysis of inhaled salmeterol in asthma patients: Evidence from two dry powder inhalers.哮喘患者吸入沙美特罗的药代动力学分析:来自两种干粉吸入器的证据。
Biopharm Drug Dispos. 2017 Oct;38(7):407-419. doi: 10.1002/bdd.2077. Epub 2017 Jul 12.
2
Population pharmacokinetics of fluticasone propionate/salmeterol using two different dry powder inhalers.使用两种不同干粉吸入器的丙酸氟替卡松/沙美特罗的群体药代动力学。
Eur J Pharm Sci. 2015 Dec 1;80:33-42. doi: 10.1016/j.ejps.2015.08.009. Epub 2015 Aug 19.
3
Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.丙酸氟替卡松和沙美特罗联合干粉吸入剂(胶囊型和多剂量型)在哮喘和 COPD 患者中的药代动力学和药效学。
J Aerosol Med Pulm Drug Deliv. 2014 Aug;27(4):279-89. doi: 10.1089/jamp.2013.1040. Epub 2013 Sep 28.
4
Pharmacokinetic Models for Inhaled Fluticasone Propionate and Salmeterol Xinafoate to Quantify Batch-to-Batch Variability.吸入用丙酸氟替卡松和沙美特罗昔萘甲酸盐的药代动力学模型,用于量化批间变异性。
AAPS J. 2024 Apr 26;26(3):56. doi: 10.1208/s12248-024-00913-x.
5
In Vitro, Pharmacokinetic, Pharmacodynamic, and Safety Comparisons of Single and Combined Administration of Tiotropium and Salmeterol in COPD Patients Using Different Dry Powder Inhalers.使用不同干粉吸入器对慢性阻塞性肺疾病(COPD)患者单剂量及联合使用噻托溴铵和沙美特罗的体外药代动力学、药效学及安全性比较
AAPS J. 2015 Jul;17(4):871-80. doi: 10.1208/s12248-015-9751-7. Epub 2015 Mar 21.
6
Pharmacokinetics of Salmeterol and Fluticasone Propionate Delivered in Combination via Easyhaler and Diskus Dry Powder Inhalers in Healthy Subjects.舒利迭干粉吸入剂(沙美特罗替卡松)在健康受试者中的药代动力学。
J Aerosol Med Pulm Drug Deliv. 2018 Oct;31(5):290-297. doi: 10.1089/jamp.2017.1437. Epub 2018 Mar 1.
7
Bioequivalence of budesonide plus formoterol (BF) Spiromax® and BF Turbohaler® (with and without charcoal block) in healthy volunteers.布地奈德加福莫特罗(BF)的思力华®与BF都保®(有无活性炭块)在健康志愿者中的生物等效性。
Int J Clin Pharmacol Ther. 2015 Jul;53(7):593-602. doi: 10.5414/CP202238.
8
On the pharmacokinetics of two inhaled budesonide/formoterol combinations in asthma patients using modeling approaches.关于两种吸入用布地奈德/福莫特罗联合制剂在哮喘患者中的药代动力学的建模研究。
Pulm Pharmacol Ther. 2018 Feb;48:168-178. doi: 10.1016/j.pupt.2017.12.002. Epub 2017 Dec 6.
9
Pharmacokinetics of salmeterol and its main metabolite α-hydroxysalmeterol after acute and chronic dry powder inhalation in exercising endurance-trained men: Implications for doping control.沙美特罗及其主要代谢物 α-羟沙美特罗在进行性耐力训练的男性急性和慢性干粉吸入后的药代动力学:对兴奋剂控制的影响。
Drug Test Anal. 2021 Apr;13(4):747-761. doi: 10.1002/dta.2978. Epub 2020 Nov 23.
10
Systemic Exposures of Fluticasone Propionate and Salmeterol Following Inhalation via Metered Dose Inhaler with the Mini Spacer Compared with the Aerochamber Plus Spacer.与储雾罐加储物罐相比,使用微型储物罐通过定量吸入器吸入丙酸氟替卡松和沙美特罗后的全身暴露情况。
J Aerosol Med Pulm Drug Deliv. 2016 Aug;29(4):386-92. doi: 10.1089/jamp.2015.1236. Epub 2016 Jan 29.

引用本文的文献

1
Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery.G蛋白偶联受体的功能动力学揭示了药物发现的新途径。
Nat Rev Drug Discov. 2025 Apr;24(4):251-275. doi: 10.1038/s41573-024-01083-3. Epub 2025 Jan 2.
2
Population pharmacokinetic analysis of febuxostat with high focus on absorption kinetics and food effect.重点关注吸收动力学和食物效应的非布司他群体药代动力学分析。
BMC Pharmacol Toxicol. 2024 Aug 26;25(1):57. doi: 10.1186/s40360-024-00783-1.
3
Pharmacokinetic Models for Inhaled Fluticasone Propionate and Salmeterol Xinafoate to Quantify Batch-to-Batch Variability.
吸入用丙酸氟替卡松和沙美特罗昔萘甲酸盐的药代动力学模型,用于量化批间变异性。
AAPS J. 2024 Apr 26;26(3):56. doi: 10.1208/s12248-024-00913-x.
4
Inhibition of VMAT2 by β2-adrenergic agonists, antagonists, and the atypical antipsychotic ziprasidone.β2-肾上腺素能激动剂、拮抗剂和非典型抗精神病药齐拉西酮对 VMAT2 的抑制作用。
Commun Biol. 2022 Nov 23;5(1):1283. doi: 10.1038/s42003-022-04121-1.
5
Towards a Quantitative Mechanistic Understanding of Localized Pulmonary Tissue Retention-A Combined In Vivo/In Silico Approach Based on Four Model Drugs.基于四种模型药物的体内/计算机模拟相结合的方法,对局部肺组织滞留进行定量机制理解
Pharmaceutics. 2020 Apr 29;12(5):408. doi: 10.3390/pharmaceutics12050408.